COCH vs. MLSS, CLGN, RBOT, LFWD, NTRB, INGN, AVRO, ELDN, ENZ, and HYPR
Should you be buying Envoy Medical stock or one of its competitors? The main competitors of Envoy Medical include Milestone Scientific (MLSS), CollPlant Biotechnologies (CLGN), Vicarious Surgical (RBOT), ReWalk Robotics (LFWD), Nutriband (NTRB), Inogen (INGN), AVROBIO (AVRO), Eledon Pharmaceuticals (ELDN), Enzo Biochem (ENZ), and Hyperfine (HYPR). These companies are all part of the "medical" sector.
Milestone Scientific (NYSE:MLSS) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, community ranking, risk, earnings, valuation and institutional ownership.
Envoy Medical received 3 more outperform votes than Milestone Scientific when rated by MarketBeat users. Likewise, 100.00% of users gave Envoy Medical an outperform vote while only 0.00% of users gave Milestone Scientific an outperform vote.
Envoy Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -70.50%. Milestone Scientific's return on equity of 0.00% beat Envoy Medical's return on equity.
In the previous week, Envoy Medical's average media sentiment score of 0.00 equaled Milestone Scientific'saverage media sentiment score.
Milestone Scientific has a beta of 0.94, indicating that its share price is 6% less volatile than the S&P 500. Comparatively, Envoy Medical has a beta of 2.59, indicating that its share price is 159% more volatile than the S&P 500.
5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 25.2% of Milestone Scientific shares are held by insiders. Comparatively, 0.7% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Milestone Scientific has higher revenue and earnings than Envoy Medical.
Envoy Medical has a consensus target price of $6.00, indicating a potential upside of 70.94%. Given Milestone Scientific's higher probable upside, analysts clearly believe Envoy Medical is more favorable than Milestone Scientific.
Summary
Envoy Medical beats Milestone Scientific on 9 of the 13 factors compared between the two stocks.
Get Envoy Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for COCH and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Envoy Medical Competitors List
Related Companies and Tools
